- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Strides Pharma Science Ltd (SRID)
Strides Pharma Science Ltd stock price live, this page displays NSE SRID stock exchange data. View the SRID premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Strides Pharma Science Ltd real time stock price chart below.
What Is the Strides Pharma Science Ltd Stock Price Today?
The Strides Pharma Science Ltd stock price today is 945.35.
What Is the Stock Symbol for Strides Pharma Science Ltd?
The stock symbol for Strides Pharma Science Ltd is ""SRID.""
What Stock Exchange Does Strides Pharma Science Ltd Trade On?
Strides Pharma Science Ltd is listed and trades on the NSE stock exchange.
Is Strides Pharma Science Ltd a Good Stock to Buy?
Determining whether Strides Pharma Science Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SRID quote. (ISIN: INE939A01011)
What Is the Strides Pharma Science Ltd Stock Price Today?
The Strides Pharma Science Ltd stock price today is 945.35.
What Is the Stock Symbol for Strides Pharma Science Ltd?
The stock symbol for Strides Pharma Science Ltd is ""SRID.""
What Stock Exchange Does Strides Pharma Science Ltd Trade On?
Strides Pharma Science Ltd is listed and trades on the NSE stock exchange.
Is Strides Pharma Science Ltd a Good Stock to Buy?
Determining whether Strides Pharma Science Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SRID quote. (ISIN: INE939A01011)
945.35
-9.20(-0.96%)
Closed·
Fair Value
An estimate of a Strides Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
924.30
959.85
52 wk Range
448.91
972.00
SRID Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
SRID is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Strides Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
924.30959.85
52 wk Range
448.91972.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.42%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.42%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SRID Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Strides Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1,013.50
Upside
+7.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Strides Pharma Science Ltd Company Profile
Strides Pharma Science Limited develops and manufactures pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. The company operates through one segment: Pharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, CNS, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. In addition, the company offers market and trade in pharmaceutical and ancillary products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Compare SRID to Peers and Sector
Metrics to compare | SRID | Peers Peers - average of corresponding metrics from companies closely matching SRID: AJANTPHARM, ZYDUSLIFE, ALKEM, GLAND, APLLTD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSRIDPeersSector |
|---|---|---|---|---|
P/E Ratio | 21.7x | 28.8x | −0.5x | |
PEG Ratio | 0.00 | 0.87 | 0.00 | |
Price/Book | 3.4x | 4.6x | 2.6x | |
Price / LTM Sales | 1.9x | 4.6x | 3.2x | |
Upside (Analyst Target) | 6.2% | 6.8% | 42.0% | |
Fair Value Upside | Unlock | 0.5% | 6.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,013.50
(+7.21% Upside)
Earnings
Latest Release
Jul 29, 2025
EPS / Forecast
10.80 / --
Revenue / Forecast
11.20B / --
People Also Watch
FAQ
What Stock Exchange Does Strides Pharma Trade On?
Strides Pharma is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Strides Pharma?
The stock symbol for Strides Pharma is "SRID."
What Is the Strides Pharma Market Cap?
As of today, Strides Pharma market cap is 87.45B.
What Is Strides Pharma's Earnings Per Share (TTM)?
The Strides Pharma EPS (TTM) is 37.10.
When Is the Next Strides Pharma Earnings Date?
Strides Pharma will release its next earnings report on 23 Oct 2025.
From a Technical Analysis Perspective, Is SRID a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Strides Pharma Stock Split?
Strides Pharma has split 0 times.
How Many Employees Does Strides Pharma Have?
Strides Pharma has 3301 employees.
What is the current trading status of Strides Pharma (SRID)?
As of 30 Jul 2025, Strides Pharma (SRID) is trading at a price of 945.35, with a previous close of 954.55. The stock has fluctuated within a day range of 924.30 to 959.85, while its 52-week range spans from 448.91 to 972.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.